Home Science & Space Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense 1 month ago 1 month ago Science & Space Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense by admin 1 month ago1 month ago 1view 0 Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare. Source Like it? Share with your friends! 0 What's Your Reaction? hate 0 hate confused 0 confused fail 0 fail fun 0 fun geeky 0 geeky love 0 love lol 0 lol omg 0 omg win 0 win Posted by admin 0 Comments Cancel replyYour email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment.